Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is 43 189,96 ₴, with a 24-hour trading volume of 80,16B ₴. The asset's market cap is 38,51T ₴, after moving -0.25% in the last day.
Tokenized Eli Lilly And Co is trading at 43 301,47 ₴, with a tokenized market cap of 241,93M ₴ and a 24-hour trading volume of 90,08M ₴. The tokenized asset has moved -0.19% in the past 24 hours.